Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

Podobne zapisy

• Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
  od: Naidoo, J., i wsp.
  Wydane: (2015)
• Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1
  od: Naidoo, Jarushka, i wsp.
  Wydane: (2016)
• Targeting Immune Checkpoints: Releasing the Restraints on Anti-tumor Immunity for Patients with Melanoma
  od: Postow, Michael A., i wsp.
  Wydane: (2012)
• Immune Checkpoint PD-1/PD-L1: Is There Life Beyond Antibodies?
  od: Konstantinidou, Markella, i wsp.
  Wydane: (2018)
• Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
  od: Ruriko Ono, i wsp.
  Wydane: (2019-07-01)